| Sanjivani Paranteral Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531569 |
NSE Symbol : - |
P/E(TTM) : 59.61 |
|
ISIN Demat : INE860D01013 |
Div & Yield% : - |
EPS(TTM) : 5.92 |
|
Book Value(₹) : 27.31 |
Market Cap(₹Cr) : 412.34 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 18.13 | 16.44 | 12.86 | 14.96 | 14.00 | 12.58 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 18.13 | 16.44 | 12.86 | 14.96 | 14.00 | 12.58 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.39 | 0.09 | 0.05 | 0.25 | 0.15 | 0.06 |
| Total Income | 18.52 | 16.52 | 12.92 | 15.22 | 14.15 | 12.64 |
| Total Expenditure | 15.28 | 14.10 | 10.71 | 13.00 | 11.89 | 10.57 |
| PBIDT | 3.24 | 2.42 | 2.21 | 2.21 | 2.26 | 2.07 |
| Interest | 0.18 | 0.02 | 0.09 | 0.08 | 0.05 | 0.04 |
| PBDT | 3.06 | 2.41 | 2.12 | 2.14 | 2.22 | 2.03 |
| Depreciation | 0.15 | 0.13 | 0.24 | 0.24 | 0.23 | 0.23 |
| Tax | 0.62 | 0.56 | 0.58 | 0.25 | 0.28 | 0.25 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 2.30 | 1.71 | 1.26 | 1.65 | 1.71 | 1.55 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.30 | 1.71 | 1.26 | 1.65 | 1.71 | 1.55 |
| EPS (Unit Curr.) | 1.96 | 1.47 | 1.08 | 1.65 | 1.71 | 1.55 |
| EPS (Adj) (Unit Curr.) | 1.96 | 1.47 | 1.08 | 1.65 | 1.71 | 1.55 |
| Calculated EPS (Unit Curr.) | 1.96 | 1.47 | 1.08 | 1.65 | 1.71 | 1.55 |
| Calculated EPS (Adj) (Unit Curr.) | 1.96 | 1.47 | 1.08 | 1.65 | 1.71 | 1.55 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.86 | 5.87 | 4.31 | 6.61 | 6.83 | 6.20 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.86 | 5.87 | 4.31 | 6.61 | 6.83 | 6.20 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 11.68 | 11.68 | 11.68 | 10.00 | 10.00 | 10.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.87 | 14.72 | 17.19 | 14.77 | 16.14 | 16.45 |
| PBDTM(%) | 16.88 | 14.66 | 16.49 | 14.30 | 15.86 | 16.14 |
| PATM(%) | 12.69 | 10.40 | 9.80 | 11.03 | 12.21 | 12.32 |